GlassScriptPhysician profile
Danny Younes
NPI 1467893222
$96,876.41
in general payments reported to CMS, 2019-2025
11 companies · $40K in 2025
The $40K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.66 · 2020: $22.07 · 2022: $1,736 · 2023: $31K · 2024: $24K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $79K · Travel and Lodging: $11K · Food and Beverage: $3,853 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $78,758.00 |
| Travel and Lodging | $10,925.99 |
| Food and Beverage | $3,853.09 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $85,045.08 | 2023-2025 | Acessa Provu System |
| Hologic Sales and Service, LLC | $5,550.11 | 2022-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Intuitive Surgical, INC. | $3,401.58 | 2019-2025 | |
| Cytyc Surgical Products, LLC | $1,289.68 | 2024-2025 | Acessa Provu System, Novasure |
| Scynexis, INC. | $1,133.85 | 2022 | |
| Davol INC. | $172.32 | 2025 | Arista |
| Medtronic, INC. | $119.26 | 2024 | Ligasure |
| Stryker Corporation | $89.21 | 2022 | |
| Coopersurgical, INC. | $32.19 | 2024 | Paragard T 380a |
| Evofem Biosciences, INC. | $22.07 | 2020 | |
| Mayne Pharma Commercial LLC | $21.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Younes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.